CLINICAL AND B CELL SUBSETS BIOMARKERS OF RESPONSE TO TOCILIZUMAB IN RHEUMATOID ARTHRITIS

被引：1
|
作者：
Gremese, E. [1 ]
Tolusso, B. [1 ]
Fedele, A. L. [1 ]
Nowik, M. [1 ]
Canestri, S. [1 ]
Ferraccioli, G. [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Inst Rheumatol & Affine Sci, Div Rheumatol, Rome, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.4712
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0037
引用
收藏
页码：432 / 432
页数：1
相关论文
共 50 条
  • [1] Clinical Parameters and B Cell Subsets As Biomarkers of Response to Tocilizumab in Rheumatoid Arthritis
    Fedele, Anna Laura
    Tolusso, Barbara
    Gremese, Elisa
    Canestri, Silvia
    Di Mario, Clara
    Nowik, Marcin
    Ferraccioli, Gianfranco
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [2] Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis
    Maldonado-Montoro, Mar
    Canadas-Garre, Marisa
    Gonzalez-Utrilla, Alfonso
    Cristian Plaza-Plaza, Jose
    Angel Calleja-Hernandez, Miguel
    [J]. PHARMACOLOGICAL RESEARCH, 2016, 111 : 264 - 271
  • [3] THE INFLUENCE OF RITUXIMAB AND TOCILIZUMAB TREATMENT ON B-CELL SUBSETS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Suponitskaya, E.
    Aleksankin, A.
    Avdeeva, A.
    Aleksandrova, E.
    Novikov, A.
    Nasonov, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 498 - 498
  • [4] THE BLOOD B-CELL SUBSETS AND EFFECT OF TOCILIZUMAB THERAPY ON THEM IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Gerasimova, E.
    Popkova, T.
    Aleksankin, A.
    Davidyan, S.
    Martinova, A.
    Aleksandrova, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 950 - 951
  • [5] CLINICAL AND SEROLOGICAL RESPONSE TO TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Casu, C.
    Bruschi, E.
    Alpini, C.
    Marceglia, S.
    Giacomelli, L.
    Epis, O.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 880 - 880
  • [6] Tocilizumab modulates activation and homing receptor of peripheral memory B cell subsets in rheumatoid arthritis patients
    Mahmood, Zafar
    Schmalzing, Marc
    Doerner, Thomas
    Tony, Hans Peter
    Muhammad, Khalid
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 188 - 188
  • [7] TOCILIZUMAB LEVELS ARE ASSOCIATED WITH CLINICAL RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Kneepkens, E. L.
    Van den Oever, I. A.
    Plasencia, C.
    Salcedo Pascual, D.
    Lopez-Casla, M. T.
    Van der Kleij, D.
    Nurmohamed, M. T.
    Rispens, T.
    Balsa, A.
    Wolbink, G. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 497 - 498
  • [8] Clinical safety of tocilizumab in rheumatoid arthritis
    Bannwarth, Bernard
    Richez, Christophe
    [J]. EXPERT OPINION ON DRUG SAFETY, 2011, 10 (01) : 123 - 131
  • [9] THE CLINICAL EFFICACY OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
    Mircic, Maja
    Kavanaugh, Arthur
    [J]. DRUGS OF TODAY, 2009, 45 (03) : 189 - 197
  • [10] B Cell Activation Biomarkers as Predictive Factors for the Response to Rituximab in Rheumatoid Arthritis
    Sellam, Jeremie
    Hendel-Chavez, Houria
    Rouanet, Stephanie
    Abbed, Karim
    Combe, Bernard
    Le Loet, Xavier
    Tebib, Jacques
    Sibilia, Jean
    Taoufik, Yassine
    Dougados, Maxime
    Mariette, Xavier
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (04): : 933 - 938
12345